Background The 69th World Health Assembly approved the Global Health Sector Strategy
to eliminate hepatitis C virus (HCV) infection by 2030, which can become a reality with the …

Background The 69th World Health Assembly approved the Global Health Sector Strategy
to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis B virus (…

Objective To estimate the effectiveness of mRNA covid-19 vaccines against symptomatic
infection and severe outcomes (hospital admission or death). Design Test negative design …

Background Influenza vaccine effectiveness (VE) is generally interpreted in the context of
vaccine match/mismatch to circulating strains with evolutionary drift in the latter invoked to …

Background In late spring 2009, concern was raised in Canada that prior vaccination with the
2008–09 trivalent inactivated influenza vaccine (TIV) was associated with increased risk of …

Importance SARS-CoV-2 infection may lead to acute and chronic sequelae. Emerging evidence
suggests a higher risk of diabetes after infection, but population-based evidence is still …

Background & Aims HCV reinfection following successful treatment can compromise
treatment outcomes. This systematic review assessed the rate of HCV reinfection following …

Extensive non-pharmaceutical and physical distancing measures are currently the primary
interventions against coronavirus disease 2019 (COVID-19) worldwide. It is therefore urgent …

Background We conducted an assessment of knowledge about blood borne pathogens (BBP)
and use of universal precautions at first level care facilities (FLCF) in two districts of …

Background & Aims Direct-acting antiviral therapies (DAA) are an important tool for hepatitis
C virus (HCV) elimination. However, reinfection among people who inject drugs (PWID) may …